Similar Articles
1341 Hepatocellular carcinoma: Where are we?
1342 Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
1343 Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
1344 Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art
1345 Hepatocellular carcinoma and hepatitis B surface protein
1346 Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies
1347 Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
1348 Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysis
1349 Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
1350 Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA